The Evolving Role of Cytokine Therapy for Renal Cell Carcinoma: Past, Present, and Future

Expert guidance for physicians nurses and pharmacists on evolving cytokine therapy for RCC.

Share

Program Content

Activities

HD IL-2 in RCC
How I Am Using HD IL-2 in My Practice Today
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 24, 2020

Expires: August 23, 2021

Activities

Cytokine Therapy in RCC
The Evolving Role of Cytokine Therapy for Renal Cell Carcinoma: Past, Present, and Future
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: October 01, 2020

Expires: September 30, 2021

Slideset: Cytokine Therapy in RCC
The Evolving Role of Cytokine Therapy for Renal Cell Carcinoma: Past, Present, and Future
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 01, 2020

Expires: September 30, 2021

Activities

HD IL-2 AE Guide
Clinician’s Guide to Adverse Events Associated With High-Dose Interleukin-2
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: November 11, 2020

Expires: November 10, 2021

Faculty

cover img faculity

Brendan D. Curti, MD

Robert W. Franz Endowed Chair for Clinical Research
Earle A. Chiles Research Institute
Providence Cancer Institute
Portland, Oregon

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Clinigen Inc